Evotec AG (NASDAQ:EVTCY)

BRIEF

published on 10/29/2026 at 07:35, 3 days 3 hours ago

Evotec SE to Announce Q3 2026 Financial Results

Financial Results Conference Call Drug Discovery Evotec SE Webcast Announcement
PRESS RELEASE

published on 10/29/2026 at 07:30, 3 days 3 hours ago

Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026
BRIEF

published on 10/15/2026 at 07:35, 17 days 3 hours ago

Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer

Biotechnology Drug Discovery Evotec Joanna Holbrook Scientific Strategy
PRESS RELEASE

published on 10/15/2026 at 07:30, 17 days 3 hours ago

Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board
Evotec appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board. Dr. Holbrook brings 25+ years experience in pharma, biotech, and academia

Chief Scientific Officer Management Board Evotec Pharma Dr. Joanna Holbrook
BRIEF

published on 10/13/2026 at 22:42, 18 days 12 hours ago

Evotec Reports Nine-Month 2026 Results Surpassing Expectations

Biotechnology Financial Guidance Nine-month Results Evotec 2026 Preliminary Revenues
PRESS RELEASE

published on 10/13/2026 at 22:37, 18 days 12 hours ago

EQS-Adhoc: Ad hoc: Evotec announces preliminary nine-months 2026 results above market expectations, reaffirming full-year 2026 guidance
Evotec SE announces preliminary nine-months 2026 results above market expectations, reaffirms full-year 2026 guidance. Full financial results will be published on November 5, 2026

Evotec SE Preliminary Results Financial Forecast Market Expectations Full-year Guidance
BRIEF

published on 09/29/2026 at 07:35, 1 month 2 days ago

Evotec Announces Transition of Chief Scientific Officer

Drug Discovery Evotec SE Leadership Transition Scientific Innovation IPSC Technologies
PRESS RELEASE

published on 09/29/2026 at 07:30, 1 month 2 days ago

Evotec Announces Chief Scientific Officer Transition
Evotec SE announces the transition of Chief Scientific Officer Dr. Cord Dohrmann, effective September 30, 2026. The search for a successor is ongoing

Chief Scientific Officer Evotec SE Biotech Transition Search Ongoing
BRIEF

published on 09/09/2026 at 07:35, 1 month 22 days ago

Evotec Advances Antibodies Against Orthopoxvirus to Clinical Trials

Phase 1 Clinical Trial Evotec SE Orthopoxvirus Monoclonal Antibodies Biodefense Preparedness
PRESS RELEASE

published on 09/09/2026 at 07:30, 1 month 22 days ago

Just – Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies
Just \/ Evotec Biologics advances investigational antibodies against orthopoxviruses into Phase 1 clinical studies under U.S. Department of War Accelerated Antibodies Program, supporting biodefense preparedness

Biodefense U.S. Department Of War Orthopoxviruses Just \/ Evotec Biologics Phase 1 Clinical Studies

Published on 10/30/2026 at 23:35, 1 day 11 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 11 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 1 day 14 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 1 day 16 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 19 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/01/2026 at 10:35, 28 minutes ago

Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 6 hours 3 minutes ago

2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 18 hours 28 minutes ago

SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 12 hours ago

EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 22:30, 1 day 12 hours ago

/C O R R E C T I O N - OCI Global/

View all EQS

Published on 10/30/2026 at 23:00, 1 day 12 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 1 day 14 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 1 day 17 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 1 day 23 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 2 days 2 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News